Burow Kristina (CIK 0001569248)

Latest company ownership

Shares held
27,848,648
Last filed at
Oct 29, 2025
Confidence Score
83.8
2025Q4
Confidence Score History
2023Q3 2025Q4
Shares held
2,343,750
Last filed at
Feb 10, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4
Shares held
2,222,222
Last filed at
Oct 18, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q4 2025Q4
PRME - Prime Medicine, Inc.
Role: 10% Owner
Shares held
367,175
Last filed at
Oct 26, 2022
Confidence Score
59.4
2025Q4
Confidence Score History
2022Q4 2025Q4
Shares held
366,301
Last filed at
Apr 4, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q2 2025Q4
MTSR - Metsera, Inc.
Role: Director
Shares held
148,953
Last filed at
Nov 13, 2025
Confidence Score
50.6
2025Q4
Confidence Score History
2025Q1 2025Q4
Shares held
5,339
Last filed at
Dec 26, 2023
Confidence Score
50.1
2025Q4
Confidence Score History
2025Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 27, 2025 Oct 29, 2025 Neumora Therapeutics, Inc. Director Buy 95.0 +1,915,700 5.99% ✗ $5M
Aug 1, 2025 Aug 1, 2025 Prime Medicine, Inc. 10% Owner Buy 100.0 +3,030,300 19.61% ✗ $10M
May 29, 2025 May 30, 2025 Scholar Rock Holding Corp Director Sell 50.0 -5,400 -0.23% ✓ $160.5K
Feb 3, 2025 Feb 3, 2025 Metsera, Inc. Director Buy 97.5 +2,222,222 9.04% ✗ $40M
Apr 2, 2024 Apr 4, 2024 Boundless Bio, Inc. Director Buy 100.0 +200,000 12.01% ✗ $3.2M
Feb 15, 2024 Feb 20, 2024 Prime Medicine, Inc. 10% Owner Buy 100.0 +3,200,000 26.11% ✗ $20M
Feb 8, 2024 Feb 12, 2024 Sana Biotechnology, Inc. 10% Owner Buy 96.3 +1,818,181 5.39% ✗ $10M
Nov 13, 2023 Nov 15, 2023 Neumora Therapeutics, Inc. Director Buy 75.0 +35,010 0.85% ✗ $412.1K
Nov 8, 2023 Nov 13, 2023 Neumora Therapeutics, Inc. Director Buy 92.5 +140,605 3.54% ✗ $1.5M
Nov 3, 2023 Nov 7, 2023 Neumora Therapeutics, Inc. Director Buy 87.5 +95,694 2.47% ✗ $1.1M
Sep 28, 2023 Sep 29, 2023 Neumora Therapeutics, Inc. Director Buy 87.5 +76,511 2.02% ✗ $1M
Sep 26, 2023 Sep 27, 2023 Neumora Therapeutics, Inc. Director Buy 85.0 +58,504 1.56% ✗ $700.5K
Sep 22, 2023 Sep 25, 2023 Neumora Therapeutics, Inc. Director Buy 92.5 +100,740 2.77% ✗ $1.1M
Sep 19, 2023 Sep 20, 2023 Neumora Therapeutics, Inc. Director Buy 100.0 +1,500,000 70.62% ✗ $25.5M
Oct 24, 2022 Oct 26, 2022 Prime Medicine, Inc. 10% Owner Buy 97.5 +800,000 6.98% ✗ $13.6M
Oct 16, 2019 Oct 18, 2019 Vir Biotechnology, Inc. Director Buy 100.0 +1,000,000 100.00% ✗ $20M